Onasemnogene aveparvovec gene therapy for spinal muscular atrophy type 1 (SMA1): Phase 3 study update (STR1VE-EU) E. Mercuri, G. Baranello, R. Masson, O. Boespflug-Tanguy, C. Bruno,S. Corti, A. Daron,N. Deconinck,M. Scoto, L. Servais,V. Straub,F. Ogrinc,H. Ouyang, D. Sproule, S. Reyna, S. Tauscher-Wisniewki, F. Baldinetti,D. Chand, D. Feltner,A. Lavrov, F. MuntoniNEUROMUSCULAR DISORDERS(2020)引用 3|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要